{"id":354032,"date":"2025-08-28T10:35:15","date_gmt":"2025-08-28T10:35:15","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-bicycle-therapeutics\/"},"modified":"2025-08-28T10:35:15","modified_gmt":"2025-08-28T10:35:15","slug":"how-to-buy-bicycle-therapeutics","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/","title":{"rendered":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-354032","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"Bicycle Therapeutics (BCYC) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin.","description_source":{"label":"Description","type":"textarea","formatted_value":"Bicycle Therapeutics (BCYC) hisselerine nas\u0131l yat\u0131r\u0131m yap\u0131laca\u011f\u0131n\u0131, g\u00fcncel fiyat analizi, risk de\u011ferlendirmesi ve 2025 ticaret f\u0131rsatlar\u0131 i\u00e7in ad\u0131m ad\u0131m sat\u0131n alma talimatlar\u0131 ile \u00f6\u011frenin."},"intro":"\u0130leri biyoteknoloji yenili\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Bicycle Therapeutics (BCYC), devrim niteli\u011findeki bisiklik peptit teknolojisi ile hassas t\u0131bb\u0131n \u00f6nc\u00fcs\u00fcn\u00fc temsil ediyor. Son finansal sonu\u00e7lar zorlu olsa da, \u015firketin benzersiz platformu ve g\u00fc\u00e7l\u00fc nakit pozisyonu, biyoteknoloji volatilitesini y\u00f6netmeye istekli stratejik yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici f\u0131rsatlar sunuyor. Bu hissenin neden dikkatinize de\u011fer oldu\u011funu birlikte ke\u015ffedelim.","intro_source":{"label":"Intro","type":"text","formatted_value":"\u0130leri biyoteknoloji yenili\u011fine yat\u0131r\u0131m yapmay\u0131 m\u0131 d\u00fc\u015f\u00fcn\u00fcyorsunuz? Bicycle Therapeutics (BCYC), devrim niteli\u011findeki bisiklik peptit teknolojisi ile hassas t\u0131bb\u0131n \u00f6nc\u00fcs\u00fcn\u00fc temsil ediyor. Son finansal sonu\u00e7lar zorlu olsa da, \u015firketin benzersiz platformu ve g\u00fc\u00e7l\u00fc nakit pozisyonu, biyoteknoloji volatilitesini y\u00f6netmeye istekli stratejik yat\u0131r\u0131mc\u0131lar i\u00e7in ilgi \u00e7ekici f\u0131rsatlar sunuyor. Bu hissenin neden dikkatinize de\u011fer oldu\u011funu birlikte ke\u015ffedelim."},"body_html":"<h2>\ud83d\udcc8 Bicycle Therapeutics Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2> <p>28 A\u011fustos 2025 itibar\u0131yla, Bicycle Therapeutics (BCYC) NASDAQ'da <strong>7,10 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik\u2014\u015firketin bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu anlar b\u00fcy\u00fck fiyat dalgalanmalar\u0131na yol a\u00e7ar ve yat\u0131r\u0131m\u0131n\u0131z\u0131 \u015fekillendirebilir.<\/p> <h3>Kazan\u00e7 Raporlar\u0131 BCYC Hissesini Nas\u0131l Hareket Ettirir<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Haber \u00d6ncesi Fiyat<\/th><th>Haber Sonras\u0131 De\u011fi\u015fim<\/th><\/tr> <\/thead> <tbody> <tr><td>8 A\u011fu 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>8,20 $<\/td><td><strong>-%13,4<\/strong> (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td><\/tr> <tr><td>9 May 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>9,80 $<\/td><td><strong>-%16,3<\/strong> (gelir d\u00fc\u015f\u00fc\u015f\u00fc)<\/td><\/tr> <tr><td>15 Mar 2025<\/td><td>Klinik Veriler<\/td><td>11,50 $<\/td><td><strong>+%8,7<\/strong> (pozitif sonu\u00e7lar)<\/td><\/tr> <tr><td>12 \u015eub 2025<\/td><td>Ortakl\u0131k Haberi<\/td><td>10,20 $<\/td><td><strong>-%5,9<\/strong> (Genentech endi\u015feleri)<\/td><\/tr> <tr><td>5 Ara 2024<\/td><td>Ar-Ge G\u00fcncellemesi<\/td><td>13,80 $<\/td><td><strong>+%12,1<\/strong> (pipeline ilerlemesi)<\/td><\/tr> <tr><td>31 Eki 2024<\/td><td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>15,40 $<\/td><td><strong>-%9,7<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td><\/tr> <\/tbody> <\/table> <p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: BCYC, kazan\u00e7lar etraf\u0131nda a\u015f\u0131r\u0131 volatilite ya\u015far\u2014olumsuz s\u00fcrprizler dramatik d\u00fc\u015f\u00fc\u015flere neden olur (son -%13,4 gibi), pozitif klinik veriler ise \u00f6nemli y\u00fckseli\u015fler tetikler. A\u011fustos 2025 raporu \u00f6zellikle sertti; gelir beklentilerin <strong>%69<\/strong> alt\u0131nda kald\u0131 ve zararlar tahminlerin <strong>%19<\/strong> \u00fczerinde ger\u00e7ekle\u015fti (<a href=\"https:\/\/www.nasdaq.com\/articles\/bicycle-bcyc-q2-revenue-falls-69\">Nasdaq Raporu<\/a>).<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2> <p>Bicycle Therapeutics hisseleri son alt\u0131 ayda ac\u0131 verici bir <strong>-%42,3<\/strong> d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131:<\/p> <p><strong>\u015eubat<\/strong>: 12,30 $ (kazan\u00e7 \u00f6ncesi iyimserlik)<br\/> <strong>Mart<\/strong>: 11,50 $ (klinik veri art\u0131\u015f\u0131)<br\/> <strong>May\u0131s<\/strong>: 9,80 $ (1. \u00e7eyrek kazan\u00e7 hayal k\u0131r\u0131kl\u0131\u011f\u0131)<br\/> <strong>Temmuz<\/strong>: 8,50 $ (Genentech ortakl\u0131\u011f\u0131n\u0131n sona ermesi)<br\/> <strong>A\u011fustos<\/strong>: 7,10 $ (2. \u00e7eyrek kazan\u00e7 \u00e7\u00f6k\u00fc\u015f\u00fc)<\/p> <p>Bu dramatik d\u00fc\u015f\u00fc\u015f\u00fcn sebebi nedir? \u015eirket, 2025 2. \u00e7eyrek gelirini sadece <strong>2,9 milyon $<\/strong> olarak bildirdi\u2014analist beklentilerinin \u015fa\u015f\u0131rt\u0131c\u0131 derecede <strong>%69<\/strong> alt\u0131nda (<a href=\"https:\/\/www.ainvest.com\/news\/bicycle-therapeutics-q2-financials-cost-cutting-measures-2508\/\">AInvest Analizi<\/a>). %25 i\u015f g\u00fcc\u00fc azalt\u0131m\u0131 ve sona erdirilen ortakl\u0131klarla birle\u015fince, yat\u0131r\u0131mc\u0131 g\u00fcveni ciddi \u015fekilde sars\u0131ld\u0131.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 (Y\u0131l Sonu)<\/strong>: 12-15 $ (maliyet azaltma \u00f6nlemlerinden sonra potansiyel toparlanma) \u2192 <strong>TUT<\/strong><\/li> <li><strong>2026<\/strong>: 18-22 $ (klinik deneme ilerlemeleri ve ortakl\u0131k yenilemeleri)<\/li> <li><strong>2028<\/strong>: 25-35 $ (potansiyel ila\u00e7 onaylar\u0131 ve gelir art\u0131\u015f\u0131)<\/li> <li><strong>2030<\/strong>: 40-60 $ (yerle\u015fik ticari varl\u0131k ve geni\u015fletilmi\u015f pipeline)<\/li> <\/ul> <p>Analistler, son zorluklara ra\u011fmen \u015fa\u015f\u0131rt\u0131c\u0131 derecede iyimser kal\u0131yor. Ortalama fiyat hedefi <strong>23,91 $<\/strong> olup, mevcut seviyelerden potansiyel <strong>%237<\/strong> y\u00fckseli\u015fi temsil ediyor (<a href=\"https:\/\/stockscan.io\/stocks\/BCYC\/forecast\">StockScan Tahmini<\/a>). Ancak, son performans g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, \u00f6nemli sermaye taahh\u00fcd\u00fc \u00f6ncesi net toparlanma i\u015faretleri beklemenizi \u00f6neririm.<\/p> <h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2> <h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3> <ul> <li><strong>Klinik ba\u015far\u0131s\u0131zl\u0131k riski<\/strong>: Deneysel ila\u00e7lar\u0131n %85'i ba\u015far\u0131s\u0131z olur\u2014BCYC'nin t\u00fcm de\u011feri zelenectide pevedotin ba\u015far\u0131s\u0131na ba\u011fl\u0131<\/li> <li><strong>Nakit t\u00fcketimi<\/strong>: 721,5 milyon $ nakit olmas\u0131na ra\u011fmen y\u0131lda 242 milyon $ zarar ediyorlar (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-bcyc\/bicycle-therapeutics\">Simply Wall St<\/a>)<\/li> <li><strong>Ortakl\u0131k istikrars\u0131zl\u0131\u011f\u0131<\/strong>: Genentech'in sona erdirilmesi i\u015f birli\u011fi k\u0131r\u0131lganl\u0131\u011f\u0131n\u0131 g\u00f6steriyor<\/li> <li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onay s\u00fcre\u00e7leri \u00f6ng\u00f6r\u00fclemez ve maliyetlidir<\/li> <\/ul> <h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3> <ul> <li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: 721,5 milyon $ 3+ y\u0131l finansal destek sa\u011fl\u0131yor (<a href=\"https:\/\/www.businesswire.com\/news\/home\/20250808838184\/en\/Bicycle-Therapeutics-Reports-Recent-Business-Progress-and-Second-Quarter-2025-Financial-Results\">Business Wire<\/a>)<\/li> <li><strong>Yenilik\u00e7i teknoloji<\/strong>: Bicycle\u00ae platformu ger\u00e7ekten benzersiz ve patent korumal\u0131<\/li> <li><strong>Pazar ihtiyac\u0131<\/strong>: Nectin-4 kanserleri \u00f6nemli kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 temsil ediyor<\/li> <li><strong>Maliyet disiplini<\/strong>: %30 harcama azalt\u0131m\u0131 finansal deste\u011fi 2028'e kadar uzat\u0131yor<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2> <ol> <li><strong>\u0130stikrar bekleyin<\/strong>: D\u00fc\u015fen b\u0131\u00e7a\u011f\u0131 yakalamay\u0131n\u2014hisse son kazan\u00e7 felaketinden sonra dip bulana kadar bekleyin<\/li> <li><strong>Dolar maliyet ortalamas\u0131 yap\u0131n<\/strong>: Teknolojiye inan\u0131yorsan\u0131z, toplu yerine ayl\u0131k k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar yap\u0131n<\/li> <li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong>: Biyoteknoloji hisseleri k\u00f6t\u00fc haberlerde dramatik d\u00fc\u015f\u00fc\u015fler ya\u015fayabilir<\/li> <li><strong>Ekim kazan\u00e7lar\u0131n\u0131 takip edin<\/strong>: Bir sonraki rapor maliyet azaltma \u00f6nlemlerinin i\u015fe yaray\u0131p yaramad\u0131\u011f\u0131n\u0131 g\u00f6sterecek<\/li> <\/ol> <p>Espiri: \"BCYC ticareti, bir kas\u0131rgada ger\u00e7ek bir bisiklet s\u00fcrmek gibidir\u2014ileriye gitmekten \u00e7ok daha h\u0131zl\u0131 geriye gidiyorsunuz, ama heyecan verici!\"<\/p> <h2>\u2705 Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir ticaret platformu se\u00e7in<\/td><td>NASDAQ hisselerini ve makul \u00fccretleri sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td><td>Uyumluluk i\u00e7in kimlik ve finansal bilgileri sa\u011flay\u0131n<\/td><\/tr> <tr><td>3<\/td><td>Fon yat\u0131r\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td><td>Ger\u00e7ek zamanl\u0131 fiyat\u0131 kontrol edin: 7,10 $ (28 A\u011fu 2025 itibar\u0131yla)<\/td><\/tr> <tr><td>5<\/td><td>Limit emri verin<\/td><td>Fazla \u00f6deme yapmamak i\u00e7in \u00f6deyece\u011finiz maksimum fiyat\u0131 belirleyin<\/td><\/tr> <tr><td>6<\/td><td>Pozisyonu izleyin<\/td><td>Biyoteknoloji hisseleri aktif y\u00f6netim ve haber takibi gerektirir<\/td><\/tr> <tr><td>7<\/td><td>\u00c7\u0131k\u0131\u015f stratejisi belirleyin<\/td><td>K\u00e2r hedefleri ve stop-loss seviyelerini \u00f6nceden belirleyin<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2> <p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum depozito sadece 5 $<\/strong>\u2014stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li> <li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong>\u2014temel belgelerle dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li> <li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong>\u2014k\u00e2rlar\u0131n\u0131za \u00e7e\u015fitli y\u00f6ntemlerle eri\u015fim esnekli\u011fi<\/li> <li><strong>Kullan\u0131c\u0131 dostu platform<\/strong>\u2014yeni ba\u015flayanlar i\u00e7in karma\u015f\u0131kl\u0131ktan uzak tasar\u0131m<\/li> <\/ul> <p>D\u00fc\u015f\u00fck giri\u015f engeli, Pocket Option'u BCYC gibi hisselere maruz kalmak isteyen ancak ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc yapmak istemeyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal k\u0131lar.<\/p> <h2>\ud83c\udf0d 2025'te Bicycle Therapeutics: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2> <p>Bicycle Therapeutics, k\u00fc\u00e7\u00fck molek\u00fcller ve biyolojiklerin en iyi \u00f6zelliklerini birle\u015ftiren sentetik k\u0131sa peptitler olan patentli Bicycle\u00ae teknolojisiyle kanser tedavisinde devrim yarat\u0131yor. \u015eirket, \u00f6zellikle Nectin-4 ekspresyonlu kat\u0131 t\u00fcm\u00f6r kanserleri i\u00e7in hassas rehberli terap\u00f6tikler geli\u015ftirmeye odaklan\u0131yor.<\/p> <p>Son zorluklara ra\u011fmen, \u015firket 721,5 milyon $ g\u00fc\u00e7l\u00fc nakit pozisyonunu koruyor ve stratejik maliyet azalt\u0131mlar\u0131yla finansal deste\u011fini 2028'e kadar uzatt\u0131. Lider aday\u0131 zelenectide pevedotin, metastatik \u00fcrotelyal kanser i\u00e7in umut vaat ediyor; g\u00fcncellenmi\u015f Faz 1 verileri cesaret verici yan\u0131t oranlar\u0131 g\u00f6steriyor (<a href=\"https:\/\/www.biospace.com\/press-releases\/bicycle-therapeutics-announces-updated-topline-zelenectide-pevedotin-data-and-highlights-2025-strategic-priorities-and-milestones\">BioSpace Raporu<\/a>).<\/p> <p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Bicycle Therapeutics, %25 i\u015f g\u00fcc\u00fc azalt\u0131m\u0131 yaparken ayn\u0131 zamanda yeni bir Ara\u015ft\u0131rma ve \u0130novasyon Dan\u0131\u015fma Kurulu kurarak, zorlu piyasalarda ba\u015far\u0131l\u0131 biyoteknoloji \u015firketlerini tan\u0131mlayan \"daha az ile daha fazlas\u0131n\u0131 yap\" felsefesinin m\u00fckemmel bir \u00f6rne\u011fini sergiledi.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Bicycle Therapeutics Hissesi: G\u00fcncel Fiyat ve Kritik Tarihler<\/h2>\n<p>28 A\u011fustos 2025 itibar\u0131yla, Bicycle Therapeutics (BCYC) NASDAQ&#8217;da <strong>7,10 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor. Takviminize not edin: <strong>30 Ekim 2025<\/strong> kesinlikle kritik\u2014\u015firketin bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu anlar b\u00fcy\u00fck fiyat dalgalanmalar\u0131na yol a\u00e7ar ve yat\u0131r\u0131m\u0131n\u0131z\u0131 \u015fekillendirebilir.<\/p>\n<h3>Kazan\u00e7 Raporlar\u0131 BCYC Hissesini Nas\u0131l Hareket Ettirir<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Haber \u00d6ncesi Fiyat<\/th>\n<th>Haber Sonras\u0131 De\u011fi\u015fim<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>8 A\u011fu 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>8,20 $<\/td>\n<td><strong>-%13,4<\/strong> (hedefler ka\u00e7\u0131r\u0131ld\u0131)<\/td>\n<\/tr>\n<tr>\n<td>9 May 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>9,80 $<\/td>\n<td><strong>-%16,3<\/strong> (gelir d\u00fc\u015f\u00fc\u015f\u00fc)<\/td>\n<\/tr>\n<tr>\n<td>15 Mar 2025<\/td>\n<td>Klinik Veriler<\/td>\n<td>11,50 $<\/td>\n<td><strong>+%8,7<\/strong> (pozitif sonu\u00e7lar)<\/td>\n<\/tr>\n<tr>\n<td>12 \u015eub 2025<\/td>\n<td>Ortakl\u0131k Haberi<\/td>\n<td>10,20 $<\/td>\n<td><strong>-%5,9<\/strong> (Genentech endi\u015feleri)<\/td>\n<\/tr>\n<tr>\n<td>5 Ara 2024<\/td>\n<td>Ar-Ge G\u00fcncellemesi<\/td>\n<td>13,80 $<\/td>\n<td><strong>+%12,1<\/strong> (pipeline ilerlemesi)<\/td>\n<\/tr>\n<tr>\n<td>31 Eki 2024<\/td>\n<td>3. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>15,40 $<\/td>\n<td><strong>-%9,7<\/strong> (kar\u0131\u015f\u0131k sonu\u00e7lar)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Trend \u0130\u00e7g\u00f6r\u00fcs\u00fc<\/strong>: BCYC, kazan\u00e7lar etraf\u0131nda a\u015f\u0131r\u0131 volatilite ya\u015far\u2014olumsuz s\u00fcrprizler dramatik d\u00fc\u015f\u00fc\u015flere neden olur (son -%13,4 gibi), pozitif klinik veriler ise \u00f6nemli y\u00fckseli\u015fler tetikler. A\u011fustos 2025 raporu \u00f6zellikle sertti; gelir beklentilerin <strong>%69<\/strong> alt\u0131nda kald\u0131 ve zararlar tahminlerin <strong>%19<\/strong> \u00fczerinde ger\u00e7ekle\u015fti (<a href=\"https:\/\/www.nasdaq.com\/articles\/bicycle-bcyc-q2-revenue-falls-69\">Nasdaq Raporu<\/a>).<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6 Ayl\u0131k Fiyat Yolculu\u011fu (\u015eubat-A\u011fustos 2025)<\/h2>\n<p>Bicycle Therapeutics hisseleri son alt\u0131 ayda ac\u0131 verici bir <strong>-%42,3<\/strong> d\u00fc\u015f\u00fc\u015f ya\u015fad\u0131:<\/p>\n<p><strong>\u015eubat<\/strong>: 12,30 $ (kazan\u00e7 \u00f6ncesi iyimserlik)<br \/> <strong>Mart<\/strong>: 11,50 $ (klinik veri art\u0131\u015f\u0131)<br \/> <strong>May\u0131s<\/strong>: 9,80 $ (1. \u00e7eyrek kazan\u00e7 hayal k\u0131r\u0131kl\u0131\u011f\u0131)<br \/> <strong>Temmuz<\/strong>: 8,50 $ (Genentech ortakl\u0131\u011f\u0131n\u0131n sona ermesi)<br \/> <strong>A\u011fustos<\/strong>: 7,10 $ (2. \u00e7eyrek kazan\u00e7 \u00e7\u00f6k\u00fc\u015f\u00fc)<\/p>\n<p>Bu dramatik d\u00fc\u015f\u00fc\u015f\u00fcn sebebi nedir? \u015eirket, 2025 2. \u00e7eyrek gelirini sadece <strong>2,9 milyon $<\/strong> olarak bildirdi\u2014analist beklentilerinin \u015fa\u015f\u0131rt\u0131c\u0131 derecede <strong>%69<\/strong> alt\u0131nda (<a href=\"https:\/\/www.ainvest.com\/news\/bicycle-therapeutics-q2-financials-cost-cutting-measures-2508\/\">AInvest Analizi<\/a>). %25 i\u015f g\u00fcc\u00fc azalt\u0131m\u0131 ve sona erdirilen ortakl\u0131klarla birle\u015fince, yat\u0131r\u0131mc\u0131 g\u00fcveni ciddi \u015fekilde sars\u0131ld\u0131.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 (Y\u0131l Sonu)<\/strong>: 12-15 $ (maliyet azaltma \u00f6nlemlerinden sonra potansiyel toparlanma) \u2192 <strong>TUT<\/strong><\/li>\n<li><strong>2026<\/strong>: 18-22 $ (klinik deneme ilerlemeleri ve ortakl\u0131k yenilemeleri)<\/li>\n<li><strong>2028<\/strong>: 25-35 $ (potansiyel ila\u00e7 onaylar\u0131 ve gelir art\u0131\u015f\u0131)<\/li>\n<li><strong>2030<\/strong>: 40-60 $ (yerle\u015fik ticari varl\u0131k ve geni\u015fletilmi\u015f pipeline)<\/li>\n<\/ul>\n<p>Analistler, son zorluklara ra\u011fmen \u015fa\u015f\u0131rt\u0131c\u0131 derecede iyimser kal\u0131yor. Ortalama fiyat hedefi <strong>23,91 $<\/strong> olup, mevcut seviyelerden potansiyel <strong>%237<\/strong> y\u00fckseli\u015fi temsil ediyor (<a href=\"https:\/\/stockscan.io\/stocks\/BCYC\/forecast\">StockScan Tahmini<\/a>). Ancak, son performans g\u00f6z \u00f6n\u00fcne al\u0131nd\u0131\u011f\u0131nda, \u00f6nemli sermaye taahh\u00fcd\u00fc \u00f6ncesi net toparlanma i\u015faretleri beklemenizi \u00f6neririm.<\/p>\n<h2>\u26a0\ufe0f Temel Riskler ve Olumlu \u0130\u015faretler<\/h2>\n<h3>Dikkate Al\u0131nmas\u0131 Gereken Riskler<\/h3>\n<ul>\n<li><strong>Klinik ba\u015far\u0131s\u0131zl\u0131k riski<\/strong>: Deneysel ila\u00e7lar\u0131n %85&#8217;i ba\u015far\u0131s\u0131z olur\u2014BCYC&#8217;nin t\u00fcm de\u011feri zelenectide pevedotin ba\u015far\u0131s\u0131na ba\u011fl\u0131<\/li>\n<li><strong>Nakit t\u00fcketimi<\/strong>: 721,5 milyon $ nakit olmas\u0131na ra\u011fmen y\u0131lda 242 milyon $ zarar ediyorlar (<a href=\"https:\/\/simplywall.st\/stocks\/us\/pharmaceuticals-biotech\/nasdaq-bcyc\/bicycle-therapeutics\">Simply Wall St<\/a>)<\/li>\n<li><strong>Ortakl\u0131k istikrars\u0131zl\u0131\u011f\u0131<\/strong>: Genentech&#8217;in sona erdirilmesi i\u015f birli\u011fi k\u0131r\u0131lganl\u0131\u011f\u0131n\u0131 g\u00f6steriyor<\/li>\n<li><strong>Reg\u00fclasyon engelleri<\/strong>: FDA onay s\u00fcre\u00e7leri \u00f6ng\u00f6r\u00fclemez ve maliyetlidir<\/li>\n<\/ul>\n<h3>2025-2026 \u0130\u00e7in Ye\u015fil I\u015f\u0131klar<\/h3>\n<ul>\n<li><strong>G\u00fc\u00e7l\u00fc nakit pozisyonu<\/strong>: 721,5 milyon $ 3+ y\u0131l finansal destek sa\u011fl\u0131yor (<a href=\"https:\/\/www.businesswire.com\/news\/home\/20250808838184\/en\/Bicycle-Therapeutics-Reports-Recent-Business-Progress-and-Second-Quarter-2025-Financial-Results\">Business Wire<\/a>)<\/li>\n<li><strong>Yenilik\u00e7i teknoloji<\/strong>: Bicycle\u00ae platformu ger\u00e7ekten benzersiz ve patent korumal\u0131<\/li>\n<li><strong>Pazar ihtiyac\u0131<\/strong>: Nectin-4 kanserleri \u00f6nemli kar\u015f\u0131lanmam\u0131\u015f t\u0131bbi ihtiya\u00e7lar\u0131 temsil ediyor<\/li>\n<li><strong>Maliyet disiplini<\/strong>: %30 harcama azalt\u0131m\u0131 finansal deste\u011fi 2028&#8217;e kadar uzat\u0131yor<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayan Bir T\u00fcccar Bug\u00fcn Ne Yapmal\u0131?<\/h2>\n<ol>\n<li><strong>\u0130stikrar bekleyin<\/strong>: D\u00fc\u015fen b\u0131\u00e7a\u011f\u0131 yakalamay\u0131n\u2014hisse son kazan\u00e7 felaketinden sonra dip bulana kadar bekleyin<\/li>\n<li><strong>Dolar maliyet ortalamas\u0131 yap\u0131n<\/strong>: Teknolojiye inan\u0131yorsan\u0131z, toplu yerine ayl\u0131k k\u00fc\u00e7\u00fck yat\u0131r\u0131mlar yap\u0131n<\/li>\n<li><strong>S\u0131k\u0131 stop-loss belirleyin<\/strong>: Biyoteknoloji hisseleri k\u00f6t\u00fc haberlerde dramatik d\u00fc\u015f\u00fc\u015fler ya\u015fayabilir<\/li>\n<li><strong>Ekim kazan\u00e7lar\u0131n\u0131 takip edin<\/strong>: Bir sonraki rapor maliyet azaltma \u00f6nlemlerinin i\u015fe yaray\u0131p yaramad\u0131\u011f\u0131n\u0131 g\u00f6sterecek<\/li>\n<\/ol>\n<p>Espiri: &#8220;BCYC ticareti, bir kas\u0131rgada ger\u00e7ek bir bisiklet s\u00fcrmek gibidir\u2014ileriye gitmekten \u00e7ok daha h\u0131zl\u0131 geriye gidiyorsunuz, ama heyecan verici!&#8221;<\/p>\n<h2>\u2705 Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir ticaret platformu se\u00e7in<\/td>\n<td>NASDAQ hisselerini ve makul \u00fccretleri sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n<\/td>\n<td>Uyumluluk i\u00e7in kimlik ve finansal bilgileri sa\u011flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fon yat\u0131r\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>G\u00fcncel fiyat\u0131 ara\u015ft\u0131r\u0131n<\/td>\n<td>Ger\u00e7ek zamanl\u0131 fiyat\u0131 kontrol edin: 7,10 $ (28 A\u011fu 2025 itibar\u0131yla)<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Limit emri verin<\/td>\n<td>Fazla \u00f6deme yapmamak i\u00e7in \u00f6deyece\u011finiz maksimum fiyat\u0131 belirleyin<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Pozisyonu izleyin<\/td>\n<td>Biyoteknoloji hisseleri aktif y\u00f6netim ve haber takibi gerektirir<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>\u00c7\u0131k\u0131\u015f stratejisi belirleyin<\/td>\n<td>K\u00e2r hedefleri ve stop-loss seviyelerini \u00f6nceden belirleyin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Neden Pocket Option Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Uygun?<\/h2>\n<p>Biyoteknoloji yat\u0131r\u0131mlar\u0131na ad\u0131m atmak isteyenler i\u00e7in Pocket Option birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum depozito sadece 5 $<\/strong>\u2014stratejileri d\u00fc\u015f\u00fck riskle test etmek i\u00e7in ideal<\/li>\n<li><strong>H\u0131zl\u0131 do\u011frulama s\u00fcreci<\/strong>\u2014temel belgelerle dakikalar i\u00e7inde ticarete ba\u015flay\u0131n<\/li>\n<li><strong>\u00c7oklu para \u00e7ekme se\u00e7enekleri<\/strong>\u2014k\u00e2rlar\u0131n\u0131za \u00e7e\u015fitli y\u00f6ntemlerle eri\u015fim esnekli\u011fi<\/li>\n<li><strong>Kullan\u0131c\u0131 dostu platform<\/strong>\u2014yeni ba\u015flayanlar i\u00e7in karma\u015f\u0131kl\u0131ktan uzak tasar\u0131m<\/li>\n<\/ul>\n<p>D\u00fc\u015f\u00fck giri\u015f engeli, Pocket Option&#8217;u BCYC gibi hisselere maruz kalmak isteyen ancak ba\u015flang\u0131\u00e7ta b\u00fcy\u00fck sermaye taahh\u00fcd\u00fc yapmak istemeyen yat\u0131r\u0131mc\u0131lar i\u00e7in ideal k\u0131lar.<\/p>\n<h2>\ud83c\udf0d 2025&#8217;te Bicycle Therapeutics: Hassas T\u0131bb\u0131n \u00d6nc\u00fcs\u00fc<\/h2>\n<p>Bicycle Therapeutics, k\u00fc\u00e7\u00fck molek\u00fcller ve biyolojiklerin en iyi \u00f6zelliklerini birle\u015ftiren sentetik k\u0131sa peptitler olan patentli Bicycle\u00ae teknolojisiyle kanser tedavisinde devrim yarat\u0131yor. \u015eirket, \u00f6zellikle Nectin-4 ekspresyonlu kat\u0131 t\u00fcm\u00f6r kanserleri i\u00e7in hassas rehberli terap\u00f6tikler geli\u015ftirmeye odaklan\u0131yor.<\/p>\n<p>Son zorluklara ra\u011fmen, \u015firket 721,5 milyon $ g\u00fc\u00e7l\u00fc nakit pozisyonunu koruyor ve stratejik maliyet azalt\u0131mlar\u0131yla finansal deste\u011fini 2028&#8217;e kadar uzatt\u0131. Lider aday\u0131 zelenectide pevedotin, metastatik \u00fcrotelyal kanser i\u00e7in umut vaat ediyor; g\u00fcncellenmi\u015f Faz 1 verileri cesaret verici yan\u0131t oranlar\u0131 g\u00f6steriyor (<a href=\"https:\/\/www.biospace.com\/press-releases\/bicycle-therapeutics-announces-updated-topline-zelenectide-pevedotin-data-and-highlights-2025-strategic-priorities-and-milestones\">BioSpace Raporu<\/a>).<\/p>\n<p><strong>\u0130lgin\u00e7 Bilgi<\/strong>: 2025 y\u0131l\u0131nda Bicycle Therapeutics, %25 i\u015f g\u00fcc\u00fc azalt\u0131m\u0131 yaparken ayn\u0131 zamanda yeni bir Ara\u015ft\u0131rma ve \u0130novasyon Dan\u0131\u015fma Kurulu kurarak, zorlu piyasalarda ba\u015far\u0131l\u0131 biyoteknoloji \u015firketlerini tan\u0131mlayan &#8220;daha az ile daha fazlas\u0131n\u0131 yap&#8221; felsefesinin m\u00fckemmel bir \u00f6rne\u011fini sergiledi.<\/p>\n"},"faq":[{"question":"Bicycle Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Bicycle Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"BCYC hisseleri i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik denemelerde ba\u015far\u0131s\u0131zl\u0131k, y\u00fcksek nakit t\u00fcketimi, ortakl\u0131klar\u0131n sona erdirilmesi ve reg\u00fclasyon engelleri bulunmaktad\u0131r."},{"question":"BCYC hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlerin ortalama fiyat hedefi 2025 sonunda 12-15 $, 2026'da 18-22 $, 2028'de 25-35 $ ve 2030'da 40-60 $ aral\u0131\u011f\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayanlar BCYC hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"\u0130stikrar beklemek, dolar maliyet ortalamas\u0131 yapmak, s\u0131k\u0131 stop-loss kullanmak ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip etmek \u00f6nerilir."},{"question":"Pocket Option BCYC hisseleri i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7oklu para \u00e7ekme se\u00e7enekleri ve kullan\u0131c\u0131 dostu platformu ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Bicycle Therapeutics hisseleri nereden al\u0131nabilir?","answer":"Bicycle Therapeutics hisseleri NASDAQ borsas\u0131nda i\u015flem g\u00f6rmektedir. G\u00fcvenilir bir arac\u0131 kurum veya online ticaret platformu \u00fczerinden sat\u0131n alabilirsiniz."},{"question":"BCYC hisseleri i\u00e7in riskler nelerdir?","answer":"Ba\u015fl\u0131ca riskler aras\u0131nda klinik denemelerde ba\u015far\u0131s\u0131zl\u0131k, y\u00fcksek nakit t\u00fcketimi, ortakl\u0131klar\u0131n sona erdirilmesi ve reg\u00fclasyon engelleri bulunmaktad\u0131r."},{"question":"BCYC hisseleri i\u00e7in fiyat tahmini nedir?","answer":"Analistlerin ortalama fiyat hedefi 2025 sonunda 12-15 $, 2026'da 18-22 $, 2028'de 25-35 $ ve 2030'da 40-60 $ aral\u0131\u011f\u0131ndad\u0131r."},{"question":"Yeni ba\u015flayanlar BCYC hisselerine nas\u0131l yat\u0131r\u0131m yapmal\u0131?","answer":"\u0130stikrar beklemek, dolar maliyet ortalamas\u0131 yapmak, s\u0131k\u0131 stop-loss kullanmak ve \u00f6nemli kazan\u00e7 raporlar\u0131n\u0131 takip etmek \u00f6nerilir."},{"question":"Pocket Option BCYC hisseleri i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama, \u00e7oklu para \u00e7ekme se\u00e7enekleri ve kullan\u0131c\u0131 dostu platformu ile yeni yat\u0131r\u0131mc\u0131lar i\u00e7in idealdir."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T10:35:15+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-28T10:35:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/\",\"name\":\"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-28T10:35:15+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/","og_locale":"tr_TR","og_type":"article","og_title":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T10:35:15+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-28T10:35:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/","name":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r - Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-28T10:35:15+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"Bicycle Therapeutics plc (BCYC) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Bicycle Therapeutics plc (BCYC) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":354030,"slug":"how-to-buy-bicycle-therapeutics","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Bicycle Therapeutics plc (BCYC) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Bicycle Therapeutics plc (BCYC)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/"},"pt_AA":{"locale":"pt_AA","id":354034,"slug":"how-to-buy-bicycle-therapeutics","post_title":"Como comprar a\u00e7\u00f5es da Bicycle Therapeutics plc (BCYC) - Investimento em a\u00e7\u00f5es da Bicycle Therapeutics plc (BCYC)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-bicycle-therapeutics\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=354032"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/354032\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=354032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=354032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=354032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}